SAM
BSX icon

Storebrand Asset Management’s Boston Scientific BSX Stock Holding History

Storebrand Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.6M Buy
1,232,856
+35,877
+3% +$1.95M 0.13% 158
2026
Q1 		$75.1M Sell
1,196,979
-224,233
-16% -$17.9M 0.22% 108
2025
Q4 		$136M Sell
1,421,212
-117,628
-8% -$11.5M 0.36% 54
2025
Q3 		$150M Buy
1,538,840
+92,099
+6% +$9.54M 0.4% 42
2025
Q2 		$155M Sell
1,446,741
-5,798
-0.4% -$587K 0.45% 38
2025
Q1 		$147M Buy
1,452,539
+25,977
+2% +$2.62M 0.48% 36
2024
Q4 		$127M Buy
1,426,562
+124,541
+10% +$11M 0.39% 41
2024
Q3 		$109M Buy
1,302,021
+78,344
+6% +$6.18M 0.34% 63
2024
Q2 		$94.2M Buy
1,223,677
+40,759
+3% +$2.98M 0.31% 71
2024
Q1 		$81M Sell
1,182,918
-93,954
-7% -$6.04M 0.28% 85
2023
Q4 		$73.8M Buy
1,276,872
+67,553
+6% +$3.61M 0.27% 87
2023
Q3 		$63.9M Buy
1,209,319
+99,601
+9% +$5.22M 0.3% 74
2023
Q2 		$60M Buy
1,109,718
+166,203
+18% +$8.68M 0.27% 90
2023
Q1 		$47.2M Buy
943,515
+25,068
+3% +$1.18M 0.24% 107
2022
Q4 		$42.5M Buy
918,447
+49,125
+6% +$2.13M 0.23% 117
2022
Q3 		$33.7M Sell
869,322
-2,502
-0.3% -$100K 0.2% 128
2022
Q2 		$32.5M Sell
871,824
-2,471
-0.3% -$101K 0.18% 138
2022
Q1 		$38.7M Buy
874,295
+102,463
+13% +$4.44M 0.18% 132
2021
Q4 		$32.8M Buy
771,832
+49,987
+7% +$2.1M 0.15% 161
2021
Q3 		$31.3M Buy
721,845
+2,990
+0.4% +$132K 0.15% 160
2021
Q2 		$30.7M Sell
718,855
-10,929
-1% -$460K 0.15% 163
2021
Q1 		$28.2M Buy
729,784
+16,790
+2% +$635K 0.15% 161
2020
Q4 		$25.6M Buy
712,994
+23,491
+3% +$847K 0.15% 163
2020
Q3 		$26.3M Buy
689,503
+12,506
+2% +$482K 0.19% 121
2020
Q2 		$23.8M Buy
676,997
+14,187
+2% +$511K 0.2% 119
2020
Q1 		$21.6M Buy
+662,810
New +$25.9M 0.22% 106

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Storebrand Asset Management's BSX Position: Q2 2026 in Review

Storebrand Asset Management increased its Boston Scientific (BSX) stake by 3% in Q2 2026, buying an estimated $1.95M and bringing the position to 1,232,856 shares worth $52.6M. The position accounts for 0.13% of the portfolio, ranked #158.

Storebrand Asset Management first reported a position in BSX in Q1 2020 and has held it in 26 quarters since. The position peaked at $155M in Q2 2025. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Storebrand Asset Management held 1,232,856 shares of Boston Scientific worth $52.6M as of Q2 2026.
  • Storebrand Asset Management bought 35,877 Boston Scientific shares in Q2 2026, an estimated $1.95M.
  • Boston Scientific made up 0.13% of Storebrand Asset Management's portfolio in Q2 2026, its #158 holding.
  • Storebrand Asset Management first reported a position in Boston Scientific in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's Boston Scientific position peaked at $155M in Q2 2025.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.